{"id":418728,"date":"2023-03-03T11:29:06","date_gmt":"2023-03-03T14:29:06","guid":{"rendered":"https:\/\/www.ovigilanteonline.com.br\/site\/?p=418728"},"modified":"2023-03-03T11:29:07","modified_gmt":"2023-03-03T14:29:07","slug":"anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos","status":"publish","type":"post","link":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/","title":{"rendered":"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta quinta-feira (2), o registro de uma nova vacina para prevenir a dengue. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O imunizante, chamado Qdenga, \u00e9 fabricado pela biofarmac\u00eautica Takeda Pharma. Ele \u00e9 composto por quatro variantes diferentes do v\u00edrus causador da doen\u00e7a, conferindo maior prote\u00e7\u00e3o.<\/p><div id=\"ovigi-1097787637\" class=\"ovigi-conteudo_2-3 ovigi-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4068173061741521\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block; text-align:center;\" data-ad-client=\"ca-pub-4068173061741521\" \ndata-ad-slot=\"6460393376\" \ndata-ad-layout=\"in-article\"\ndata-ad-format=\"fluid\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><div id=\"ovigi-3820786092\" class=\"ovigi-conteudo_2-2 ovigi-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4068173061741521\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block; text-align:center;\" data-ad-client=\"ca-pub-4068173061741521\" \ndata-ad-slot=\"6460393376\" \ndata-ad-layout=\"in-article\"\ndata-ad-format=\"fluid\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><div id=\"ovigi-3852395250\" class=\"ovigi-conteudo_2 ovigi-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4068173061741521\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block; text-align:center;\" data-ad-client=\"ca-pub-4068173061741521\" \ndata-ad-slot=\"6460393376\" \ndata-ad-layout=\"in-article\"\ndata-ad-format=\"fluid\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><div id=\"ovigi-660105733\" class=\"ovigi-conteudo_2-4 ovigi-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4068173061741521\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block; text-align:center;\" data-ad-client=\"ca-pub-4068173061741521\" \ndata-ad-slot=\"6460393376\" \ndata-ad-layout=\"in-article\"\ndata-ad-format=\"fluid\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">De acordo com a Anvisa, a vacina \u00e9 indicada a crian\u00e7as acima de 4 anos, adolescentes e adultos at\u00e9 60 anos. Ele poder\u00e1 ser administrada por via subcut\u00e2nea em esquema de duas doses, com intervalo de tr\u00eas meses entre as aplica\u00e7\u00f5es.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;Na avalia\u00e7\u00e3o cl\u00ednica da vacina foi demonstrada uma efic\u00e1cia geral de 80,2% contra a dengue causada por qualquer sorotipo e independente de situa\u00e7\u00e3o sorol\u00f3gica de base para dengue (indiv\u00edduos soropositivos e soronegativos) em 12 meses ap\u00f3s administra\u00e7\u00e3o da vacina&#8221;, informa a Vigil\u00e2ncia Sanit\u00e1ria.<\/p>\n\n\n\n<p class=\"has-text-align-center has-small-font-size wp-block-paragraph\">continua depois da publicidade<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n<div id=\"ovigi-910041481\" style=\"margin-left: auto;margin-right: auto;text-align: center;\"><p><a href=\"https:\/\/www.unimed.coop.br\/web\/leopoldina\">\u00a0 <\/a><a href=\"https:\/\/www.unimed.coop.br\/web\/leopoldina\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-385612 size-full\" src=\"https:\/\/ovigilanteonline.com.br\/site\/wp-content\/uploads\/2021\/03\/UNIMED-LEOPOLDINA-SITE.jpg\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2021\/03\/UNIMED-LEOPOLDINA-SITE.jpg 300w, https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2021\/03\/UNIMED-LEOPOLDINA-SITE-100x100.jpg 100w, https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2021\/03\/UNIMED-LEOPOLDINA-SITE-150x150.jpg 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <a href=\" http:\/\/wa.me\/553234414597\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-427514 size-full\" src=\"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/11\/POLIPLAS-NOVEMBRO-jpeg.webp\" alt=\"\" width=\"301\" height=\"300\" srcset=\"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/11\/POLIPLAS-NOVEMBRO-jpeg.webp 301w, https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/11\/POLIPLAS-NOVEMBRO-150x150.webp 150w, https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/11\/POLIPLAS-NOVEMBRO-100x100.webp 100w\" sizes=\"auto, (max-width: 301px) 100vw, 301px\" \/><\/a><\/p>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">A demonstra\u00e7\u00e3o da efic\u00e1cia da vacina Qdenga foi baseada nos resultados de um estudo de larga escala, de fase 3, randomizado e controlado por placebo, conduzido em pa\u00edses em que a dengue \u00e9 endemia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O imunizante da Takeda Pharma tamb\u00e9m passou pela avalia\u00e7\u00e3o da ag\u00eancia sanit\u00e1ria europeia, tendo recebido recomenda\u00e7\u00e3o positiva para uso em pa\u00edses de baixa e m\u00e9dia renda fora da Uni\u00e3o Europeia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;Durante a an\u00e1lise t\u00e9cnica realizada pela Anvisa, realizou-se um painel para a discuss\u00e3o de alguns pontos do processo de registro com especialistas do pa\u00eds que det\u00e9m not\u00f3rio saber sobre a doen\u00e7a. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Essa discuss\u00e3o ocorreu em 10 de janeiro de 2023 e, em seguida, os especialistas apresentaram um parecer opinativo sobre o produto e sobre as condi\u00e7\u00f5es de uso pleiteadas pela empresa, com o objetivo de subsidiar a an\u00e1lise realizada pelos t\u00e9cnicos da ag\u00eancia&#8221;, afirma a Anvisa.<\/p>\n\n\n\n<p class=\"has-text-align-center has-small-font-size wp-block-paragraph\">continua depois da publicidade<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">Agora, o imunizante Qdenga poder\u00e1 ser comercializado no Brasil, desde que sejam mantidas as condi\u00e7\u00f5es aprovadas pela Vigil\u00e2ncia Sanit\u00e1ria. A vacina, contudo, segue sujeita ao monitoramento de eventos adversos por meio de a\u00e7\u00f5es de farmacovigil\u00e2ncia sob a responsabilidade da empresa.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O imunizante da Takeda Pharma \u00e9 o primeiro aprovado no pa\u00eds para um p\u00fablico mais amplo (de 4 a 60 anos). A Anvisa j\u00e1 havia aprovado a Dengvaxia, mas para uso apenas em pacientes que j\u00e1 tiveram dengue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Jornal O Vigilante Online com Jornal Hoje em Dia e Anvisa.<\/p>\n\n\n<div  class=\"ultp-post-grid-block wp-block-ultimate-post-post-grid-2 ultp-block-85de76 \"><div class=\"ultp-block-wrapper\" ><div class=\"ultp-loading\"><div class=\"ultp-loading-blocks\" style=\"width:100%;height:100%;\"><div style=\"left: 0;top: 0;animation-delay:0s;\"><\/div><div style=\"left: 21px;top: 0;animation-delay:0.125s;\"><\/div><div style=\"left: 42px;top: 0;animation-delay:0.25s;\"><\/div><div style=\"left: 0;top: 21px;animation-delay:0.875s;\"><\/div><div style=\"left: 42px;top: 21px;animation-delay:0.375s;\"><\/div><div style=\"left: 0;top: 42px;animation-delay:0.75s;\"><\/div><div style=\"left: 42px;top: 42px;animation-delay:0.625s;\"><\/div><div style=\"left: 21px;top: 42px;animation-delay:0.5s;\"><\/div><\/div><\/div><div class=\"ultp-heading-filter\"><div class=\"ultp-heading-filter-in\"><div class=\"ultp-heading-wrap ultp-heading-style1 ultp-heading-left\"><h2 class=\"ultp-heading-inner\"><span>Leia tamb\u00e9m<\/span><\/h2><\/div><\/div><\/div><div class=\"ultp-block-items-wrap ultp-block-row\"><div class=\"ultp-block-item post-id-456189\"><div class=\"ultp-block-content-wrap ultp-block-content-overlay\"><div class=\"ultp-block-image ultp-block-image-none ultp-block-image-overlay ultp-block-image-simgleGradient\"><a href=\"https:\/\/www.ovigilanteonline.com.br\/site\/2026\/08\/22\/pirapetinga-oficializa-retorno-ao-circuito-serras-e-cachoeiras-e-fortalece-o-turismo-regional-na-zona-da-mata\/\" ><img decoding=\"async\"  alt=\"Pirapetinga oficializa retorno ao Circuito Serras e Cachoeiras e fortalece o turismo regional na Zona da Mata\"  src=\"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2026\/08\/pirapetinga-870x570.jpg\" \/><\/a><\/div><div class=\"ultp-block-content ultp-block-content-bottomPosition\"><div class=\"ultp-block-content-inner\"><h3 class=\"ultp-block-title \"><a href=\"https:\/\/www.ovigilanteonline.com.br\/site\/2026\/08\/22\/pirapetinga-oficializa-retorno-ao-circuito-serras-e-cachoeiras-e-fortalece-o-turismo-regional-na-zona-da-mata\/\" >Pirapetinga oficializa retorno ao Circuito Serras e Cachoeiras e fortalece o turismo regional na Zona da Mata<\/a><\/h3><\/div><\/div><\/div><\/div><div class=\"ultp-block-item post-id-456167\"><div class=\"ultp-block-content-wrap ultp-block-content-overlay\"><div class=\"ultp-block-image ultp-block-image-none ultp-block-image-overlay ultp-block-image-simgleGradient\"><a href=\"https:\/\/www.ovigilanteonline.com.br\/site\/2026\/08\/21\/carreta-carregada-com-gas-tomba-na-br-116-em-leopoldina\/\" ><img decoding=\"async\"  alt=\"Carreta carregada com g\u00e1s tomba na BR-116 em Leopoldina\"  src=\"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2026\/08\/capa-2.jpeg\" \/><\/a><\/div><div class=\"ultp-block-content ultp-block-content-bottomPosition\"><div class=\"ultp-block-content-inner\"><h3 class=\"ultp-block-title \"><a href=\"https:\/\/www.ovigilanteonline.com.br\/site\/2026\/08\/21\/carreta-carregada-com-gas-tomba-na-br-116-em-leopoldina\/\" >Carreta carregada com g\u00e1s tomba na BR-116 em Leopoldina<\/a><\/h3><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"pagination-block-html\" aria-hidden=\"true\" style=\"display: none;\"><\/div><\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n<div class=\"ultp-not-found-message\" role=\"alert\">No Post Found<\/div>","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta quinta-feira (2), o registro de uma nova vacina para prevenir a dengue. O imunizante, chamado Qdenga, \u00e9 fabricado pela biofarmac\u00eautica Takeda Pharma. Ele \u00e9 composto por quatro variantes diferentes do v\u00edrus causador da doen\u00e7a, conferindo maior prote\u00e7\u00e3o. De acordo com a Anvisa, a vacina \u00e9 indicada [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":418729,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,26],"tags":[],"class_list":["post-418728","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-geral","category-ultimas-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta quinta-feira (2), o registro de uma nova vacina para prevenir a dengue. O imunizante, chamado Qdenga, \u00e9 fabricado pela biofarmac\u00eautica Takeda Pharma. Ele \u00e9 composto por quatro variantes diferentes do v\u00edrus causador da doen\u00e7a, conferindo maior prote\u00e7\u00e3o. De acordo com a Anvisa, a vacina \u00e9 indicada [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/\" \/>\n<meta property=\"og:site_name\" content=\"O VIGILANTE ONLINE\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ovigilanteonline\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-03T14:29:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-03T14:29:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/03\/234234.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"481\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"J\u00falio Cabral\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"J\u00falio Cabral\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/\"},\"author\":{\"name\":\"J\u00falio Cabral\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/#\\\/schema\\\/person\\\/a58c0d2b43f23d108fa2b3c67db4e4df\"},\"headline\":\"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos\",\"datePublished\":\"2023-03-03T14:29:06+00:00\",\"dateModified\":\"2023-03-03T14:29:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/\"},\"wordCount\":418,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/234234.jpg\",\"articleSection\":[\"Geral\",\"\u00daltimas Not\u00edcias\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/\",\"url\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/\",\"name\":\"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/234234.jpg\",\"datePublished\":\"2023-03-03T14:29:06+00:00\",\"dateModified\":\"2023-03-03T14:29:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/#\\\/schema\\\/person\\\/a58c0d2b43f23d108fa2b3c67db4e4df\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/234234.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/234234.jpg\",\"width\":800,\"height\":481},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/2023\\\/03\\\/03\\\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/\",\"name\":\"O VIGILANTE ONLINE - Not\u00edcias de Leopoldina e regi\u00e3o\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ovigilanteonline.com.br\\\/site\\\/#\\\/schema\\\/person\\\/a58c0d2b43f23d108fa2b3c67db4e4df\",\"name\":\"J\u00falio Cabral\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta quinta-feira (2), o registro de uma nova vacina para prevenir a dengue. O imunizante, chamado Qdenga, \u00e9 fabricado pela biofarmac\u00eautica Takeda Pharma. Ele \u00e9 composto por quatro variantes diferentes do v\u00edrus causador da doen\u00e7a, conferindo maior prote\u00e7\u00e3o. De acordo com a Anvisa, a vacina \u00e9 indicada [&hellip;]","og_url":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/","og_site_name":"O VIGILANTE ONLINE","article_publisher":"https:\/\/www.facebook.com\/ovigilanteonline","article_published_time":"2023-03-03T14:29:06+00:00","article_modified_time":"2023-03-03T14:29:07+00:00","og_image":[{"width":800,"height":481,"url":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/03\/234234.jpg","type":"image\/jpeg"}],"author":"J\u00falio Cabral","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"J\u00falio Cabral","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#article","isPartOf":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/"},"author":{"name":"J\u00falio Cabral","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/#\/schema\/person\/a58c0d2b43f23d108fa2b3c67db4e4df"},"headline":"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos","datePublished":"2023-03-03T14:29:06+00:00","dateModified":"2023-03-03T14:29:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/"},"wordCount":418,"commentCount":0,"image":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/03\/234234.jpg","articleSection":["Geral","\u00daltimas Not\u00edcias"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/","url":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/","name":"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos","isPartOf":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#primaryimage"},"image":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/03\/234234.jpg","datePublished":"2023-03-03T14:29:06+00:00","dateModified":"2023-03-03T14:29:07+00:00","author":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/#\/schema\/person\/a58c0d2b43f23d108fa2b3c67db4e4df"},"breadcrumb":{"@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#primaryimage","url":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/03\/234234.jpg","contentUrl":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-content\/uploads\/2023\/03\/234234.jpg","width":800,"height":481},{"@type":"BreadcrumbList","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/2023\/03\/03\/anvisa-aprova-vacina-contra-a-dengue-que-pode-ser-usada-em-pessoas-de-4-a-80-anos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.ovigilanteonline.com.br\/site\/"},{"@type":"ListItem","position":2,"name":"Anvisa aprova vacina contra a dengue que pode ser usada em pessoas de 4 a 80 anos"}]},{"@type":"WebSite","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/#website","url":"https:\/\/www.ovigilanteonline.com.br\/site\/","name":"O VIGILANTE ONLINE - Not\u00edcias de Leopoldina e regi\u00e3o","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ovigilanteonline.com.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/www.ovigilanteonline.com.br\/site\/#\/schema\/person\/a58c0d2b43f23d108fa2b3c67db4e4df","name":"J\u00falio Cabral"}]}},"cc_featured_image_caption":{"caption_text":"Divulga\u00e7\u00e3o","source_text":"","source_url":""},"_links":{"self":[{"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/posts\/418728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/comments?post=418728"}],"version-history":[{"count":0,"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/posts\/418728\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/media\/418729"}],"wp:attachment":[{"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/media?parent=418728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/categories?post=418728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ovigilanteonline.com.br\/site\/wp-json\/wp\/v2\/tags?post=418728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}